Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-01-2 Purity >99.0% Febuxostat Factory Intermediate
Ruifu Chemical Supply Febuxostat Navberên Têkildar:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS 25984-63-8
Ethyl 2-(3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Ethyl 2-(3-Cyano-4-Isobutoksyphenyl)-4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-01-2
Ethyl 2-(3-Formyl-4-Isobutoksyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-03-4
Ethyl 2-(4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5
Navê Kîmyewî | Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate |
Sînonîm | 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylic Acid Ethyl Ester;Febuxostat Navîn |
Hejmara CAS | 161798-01-2 |
Hejmara CAT | RF-PI1111 |
Rewşa Stock | Li Stock, Pîvana Hilberandinê heya Tonan |
Formula Molecular | C14H13NO4S |
Giraniya molekulî | 291.32 |
Melting Point | 113.0 ber 117.0℃ |
Nîşan | Ruifu Chemical |
Şanî | Specifications |
Xuyabûnî | Powderê zer berbi zer |
Çareseriya | Nimûneya 1.0 g dikare di 30 ml dichloromethane û dimethyl sulfoxide de were hilweşandin |
Nasnameya UV | Di dirêjahiya pêlên 260nm±3nm û 321nm±3nm de kişandina herî zêde |
Moisture (KF) | ≤0.50% |
Bermahî li ser Ignition | ≤0.50% |
Unknown Single Nepakî | ≤0.50% |
Tevahiya Nerazîbûnên | ≤1.0% |
Paqijî / Rêbaza Analîzê | ≥99.0% (Li ser bingeha bêhîd tê hesibandin) |
Test Standard | Enterprise Standard |
Bikaranîna | Navbera Febuxostat (CAS: 144060-53-7) |
Pakêt: Şûşek, çenteya pelê aluminum, 25kg / Druma kartonê, an li gorî hewcedariya xerîdar.
Rewşa hilanînê:Di konteynerên girtî de li cîhek sar û zuwa hilînin;Ji ronahiyê û şilbûnê biparêzin
Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate (CAS: 161798-01-2) navberek Febuxostat e (CAS: 144060-53-7).Febuxostat înhîbîtorek xanthine oxidase ya nifşê nû ye ku ji hêla Tejin Co. (Japonya) ve hatî pêşve xistin ji bo dermankirina dirêj-dirêj a hyperuicemia (gout,) mêtîngerek bijartî ya ne-purîn a nû û pir bi bandor a xanthine oxidase.Ji bo nexweşên goutê yên bêyî hyperuricemia nayê pêşniyar kirin.